Can You Have Crohn’s and Not Know It?

Crohn’s disease can be present and active in your gut for months or even years without producing symptoms obvious enough to send you to a doctor. Some people are diagnosed entirely by accident, during a colonoscopy or imaging study done for an unrelated reason. Others experience vague complaints they chalk up to stress, food sensitivities, or a sensitive stomach. The gap between when the disease actually begins and when someone gets a diagnosis is often surprisingly long, and the reasons go beyond simply “tough it out” mentality.

How Common Is Truly Silent Crohn’s?

When researchers examined a large inflammatory bowel disease registry of 2,700 Crohn’s patients, they identified 60 people whose disease was discovered incidentally while they were completely asymptomatic. That is a small fraction of the total, but it confirms that a subset of people walk around with textbook Crohn’s inflammation and feel nothing wrong. Most of those 60 patients received no treatment after their surprise diagnosis, and roughly 1 in 10 of the untreated group experienced a flare over a median follow-up of about four and a half years.¹

A separate line of evidence comes from routine colonoscopies. When people undergo the procedure for screening or other non-Crohn’s reasons, inflammation at the end of the small intestine shows up in a small but consistent percentage. A meta-analysis pooling data from over 44,000 colonoscopies found this incidental terminal ileitis in about 1.6% of cases. Among those followed over time, progression to full-blown Crohn’s was rare, but it happened.² These are not people who had suspicious symptoms and went looking for answers. They had no idea anything was wrong with their small bowel.

The Diagnostic Delay Problem

Even among people who do eventually notice something is off, the time between first symptoms and a confirmed Crohn’s diagnosis is often measured in months or years. A systematic review of 23 studies focused on Crohn’s specifically found that the median diagnostic delay ranged from 2 to over 26 months, with three-quarters of studies reporting medians between 2 and 12 months.³ That is just the delay after someone seeks help. The true gap, counting the time spent ignoring or normalizing symptoms before ever seeing a doctor, is likely longer.

Qualitative research paints a vivid picture of why. People interviewed about their diagnostic journey described limited knowledge of what “normal” bowel function even looks like. They assumed their symptoms were caused by something mild or temporary. Embarrassment kept them from bringing up bowel problems. Work pressures and distrust of doctors added more barriers. When they finally did see a general practitioner, the symptoms often looked nonspecific enough to be attributed to something else entirely. By the time a specialist referral happened, considerable time had passed.⁴

When Crohn’s Gets Mistaken for IBS

One of the most common wrong turns on the road to a Crohn’s diagnosis is being told you have irritable bowel syndrome. IBS and Crohn’s share surface-level symptoms like abdominal pain, bloating, and changes in bowel habits. But IBS does not involve the kind of intestinal inflammation and tissue damage that Crohn’s causes. A study using a large primary care database estimated that about 10% of people eventually diagnosed with inflammatory bowel disease had previously been misdiagnosed with IBS, and in roughly 3% of cases the IBS label persisted for five or more years before the true diagnosis was made.⁵

A prior diagnosis of IBS or depression can further slow down the referral process to a gastroenterologist, because clinicians may attribute new or worsening symptoms to the condition already on the chart rather than considering something new.⁶ If you have been living with an IBS diagnosis for years but your symptoms are gradually getting worse, that trajectory alone is worth raising with your doctor.

Symptoms That Do Not Look Like a Gut Disease

Part of what makes Crohn’s so easy to miss is that it does not always announce itself with classic digestive symptoms. The disease can show up first in places that seem to have nothing to do with your intestines.

Perianal fistulas, which are abnormal tunnels between the bowel and the skin near the anus, are the first sign of Crohn’s in roughly 10% of patients. And the delay between developing a fistula and getting a Crohn’s diagnosis is striking: a systematic review found that the average time to diagnosis in this group was nearly four years.⁷ These fistulas are frequently treated as routine surgical problems, and nobody thinks to look upstream at the intestine.

In children, the picture is even more deceptive. A child with undiagnosed Crohn’s may not complain of stomach pain at all. Instead, the first noticeable problem is falling off the growth chart. Growth deficiency and delayed puberty are detected in up to 85% of children eventually diagnosed with Crohn’s, and these growth changes can actually precede any gastrointestinal symptoms.⁸⁹ A pediatrician investigating short stature might consider many possibilities before inflammatory bowel disease enters the conversation.

A case report highlighted another unusual entry point: a child with a two-year history of poor growth but no digestive complaints was found to have fleshy masses around the anus. Biopsy revealed inflammatory polyps, and further workup confirmed severe Crohn’s disease. The dermatologist, not the gastroenterologist, was the one who first spotted the problem.¹⁰

Why Some People Genuinely Feel Nothing

Beyond symptoms being missed or misread, there is evidence that some people with active Crohn’s inflammation truly experience less discomfort than others with the same degree of disease. Researchers have proposed several explanations for this.

Some individuals are what clinicians informally call “stoic” patients. They feel pain or notice changes in their bowel habits but minimize or ignore the signals because they do not want the symptoms to disrupt their life. A related phenomenon involves gradual acclimation: if the inflammation develops very slowly, a person may adjust to the changes in their gut incrementally, never experiencing the kind of sudden shift that triggers alarm. And then there is a biological explanation. Researchers have found that patients with active IBD who report little to no abdominal pain are more likely to carry a specific genetic variant in a pain-sensing sodium channel gene. In other words, some people may be genetically wired to perceive gut inflammation as less painful.¹¹

This is not just an academic curiosity. It means that the absence of symptoms is not a reliable indicator that nothing is happening inside your intestines.

Silent Crohn’s Still Causes Damage

The reassuring interpretation of having Crohn’s without symptoms would be that the disease is mild and harmless. The evidence suggests otherwise for a meaningful number of people. A study tracking patients over multiple years found that those with “silent” disease, meaning low symptoms but elevated inflammatory markers like C-reactive protein, showed worsening intestinal damage over time. Compared to patients who were both symptom-free and inflammation-free, the silent group had roughly seven-fold higher odds of a worse disease trajectory.¹²

This matters because Crohn’s can cause cumulative structural problems: strictures that narrow the bowel, fistulas that connect the intestine to other organs, and abscesses. Once these develop, treatment becomes more complex and often involves surgery. Catching the inflammation before it leads to structural damage is the whole point of monitoring, and that is much harder to justify when you feel fine.

The Preclinical Window

Research into the pre-diagnostic period has revealed something striking: measurable changes in blood chemistry appear years before a Crohn’s diagnosis. One study found widespread shifts in biochemical and blood-count parameters occurring up to eight years before a formal diagnosis of Crohn’s disease.¹³ These are not changes that would trigger alarm on their own, but collectively they suggest that the immune system is gearing up for something long before gut symptoms become obvious.

Family history amplifies this concern. In a study of healthy first-degree relatives of Crohn’s patients, those from families with multiple affected members had significantly higher levels of fecal calprotectin, a protein that spills into stool when the intestinal lining is inflamed. The odds of having an elevated calprotectin level were about 50% higher in this group compared to relatives from families with only one Crohn’s patient.¹⁴ The inflammation is simmering before any symptoms develop, and in people with strong family histories, it may simmer a bit hotter.

Screening Tools for People Without Symptoms

If silent Crohn’s exists, the natural question is whether there is a way to screen for it before problems accumulate. The challenge is that the gold standard for diagnosing Crohn’s, colonoscopy with biopsy, is invasive and impractical as a screening test for the general population. Clinical guidelines for managing silent Crohn’s lean on a layered approach: start with noninvasive markers like fecal calprotectin and blood inflammatory markers, and move to colonoscopy when those raise suspicion. No single biomarker is considered superior to what you can see under a microscope.¹⁵

Fecal calprotectin is particularly useful because it is cheap, noninvasive, and reasonably sensitive. However, it is not Crohn’s-specific: any intestinal inflammation, including infections and NSAID use, can elevate it. For populations already known to be at higher risk, such as people with certain inflammatory joint diseases, fecal calprotectin screening has been studied as a way to catch silent bowel inflammation before it becomes symptomatic. The results suggest it is a useful first-pass filter, though colonoscopy and biopsy remain necessary to confirm a diagnosis.¹⁶

When Crohn’s involves only the small bowel and the affected area is beyond the reach of a standard colonoscope, capsule endoscopy offers another option. In suspected Crohn’s, the little swallowable camera has a sensitivity approaching 90%. A negative capsule study has a very high negative predictive value, ruling out Crohn’s during follow-up in about 94% of cases.¹⁷ That makes it a good tool for settling the question in ambiguous situations.

Who Should Be Thinking About This

There is no recommendation for universal Crohn’s screening, and with good reason: the disease is uncommon enough in the general population that mass screening would generate far more false alarms than real diagnoses. But certain groups have enough background risk that maintaining a low threshold of suspicion is sensible.

If you have a first-degree relative with Crohn’s, especially if more than one family member is affected, your baseline risk is elevated and subclinical inflammation may already be present. Unexplained iron deficiency, persistently loose stools, subtle weight loss, or recurrent mouth ulcers in this context deserve more than a wait-and-see approach. The same goes for people with inflammatory joint conditions, who are known to develop silent bowel inflammation at rates well above the general population.

For older adults, the picture is complicated by a wider range of conditions that can mimic Crohn’s on both imaging and biopsy. Infections, medication-related bowel injury from painkillers, poor blood flow to the intestine, and even certain cancers can look enough like inflammatory bowel disease to confuse the diagnosis.¹⁸ A diagnosis of Crohn’s in someone over 60 should be made carefully, with these alternatives systematically considered.

What Happens After an Incidental Discovery

If you are diagnosed with Crohn’s incidentally and feel perfectly well, the management decision is genuinely uncertain. In the retrospective cohort that followed 60 asymptomatic patients, the vast majority received no treatment after their surprise diagnosis. Among the untreated group, fewer than 1 in 10 experienced a flare during roughly four and a half years of follow-up. When researchers compared patients who were treated immediately to those who were not, there was no statistically significant difference in the time until a flare occurred.¹⁹

That does not mean treatment is never warranted. The study was small and observational, and the finding of silent but progressive bowel damage in other research suggests that at least some of these patients would benefit from early intervention. The emerging consensus seems to favor monitoring with periodic inflammatory markers and imaging, stepping in with treatment if objective signs of progression appear rather than waiting for symptoms to force the issue. It is the kind of decision that hinges on the location and severity of the inflammation, your risk factors for progression, and an honest conversation with your gastroenterologist about trade-offs.

Wearable Devices and the Future of Early Detection

An intriguing development is the use of consumer wearable devices to detect flares before a person feels them. A recent study found that physiological metrics collected from wearables, including heart rate, heart rate variability, step counts, and blood oxygen levels, changed significantly up to seven weeks before patients experienced an inflammatory or symptomatic flare.²⁰ The shifts were subtle enough that you would not notice them on your own, but algorithms trained on the data could pick them up.

This technology is still in the research stage, and it is unclear when or if it will translate into clinical practice. But for people already diagnosed with Crohn’s who experience quiet disease activity between flares, it represents a potential way to catch inflammation ramping up before it causes damage or symptoms. For the broader question of undiagnosed people, wearable data alone will not tell you that you have Crohn’s. But paired with family history and biomarker screening, it may eventually contribute to a more complete early-warning system.

The Cost of Delayed Diagnosis

Beyond the physical consequences, delayed diagnosis has financial implications. A Japanese cohort study found that among Crohn’s patients who required biologic therapy, those whose diagnosis was delayed by more than a year had roughly 2.6 times the odds of incurring high medical costs compared to patients diagnosed within the first month of symptoms.²¹ The likely explanation is that longer delays give the disease more time to progress to complications that require expensive treatments, including surgery. Getting diagnosed earlier does not just protect your gut. It may protect your bank account.